Elements, Radioactive

Name
Elements, Radioactive
Accession Number
DBCAT002835
Description

Elements which exhibit atomic emission due to natural or artificial nuclear transformation. These elements spontaneously undergo radioactive decay.

Drugs
DrugDrug Description
Radium Ra 223 dichlorideA radiopharmaceutical agent used to treat patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease.
Technetium Tc-99mA radiopharmaceutical indicated in imaging tests.
Bismuth subsalicylateAn antidiarrheal and anti-inflammatory agent used for symptomatic treatment of nausea, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract.
Radium Ra-223Radium 223 is under investigation in clinical trial NCT02463799 (Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC).
Bismuth subcarbonateNot Annotated
BerkeliumBerkelium is under investigation in clinical trial NCT02189122 (Comparative Effects of Aspirin and NHP-544C).
Bismuth subnitrateA medication used as an antacid.
Bismuth oxideNot Annotated
ActiniumActinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive.
Drugs & Drug Targets
DrugTargetType
Bismuth subsalicylateSerum albumincarrier
Bismuth subsalicylateSerotransferrincarrier